ICD code T59.3X2S – Toxic effect of lacrimogenic gas, intentional self-harm, sequela

Key Takeaways

T59.3X2S is a billable ICD-10-CM code: toxic effect of lacrimogenic gas, intentional self-harm, sequela – valid FY2025 and FY2026

The 7th character S signals a sequela encounter; always pair T59.3X2S with a code for the specific residual condition being treated

Character 2 (intentional self-harm) must be supported by explicit provider documentation – never inferred from clinical context alone

Pabau’s claims management software flags incomplete code structures and missing secondary codes before submission, reducing denials at the source

ICD-10 code T59.3X2S: definition, billable status, and code hierarchy

ICD-10 code T59.3X2S is the specific, billable ICD-10-CM diagnosis code for “toxic effect of lacrimogenic gas, intentional self-harm, sequela,” confirmed valid for both FY2025 and FY2026 by the CMS ICD-10-CM annual release. It sits within Chapter 19 (Injury, Poisoning and Certain Other Consequences of External Causes), and its position in the full hierarchy helps coders understand which parent categories apply when reviewing payer LCD policies or appealing claim denials.

The full code hierarchy runs: Chapter 19 (S00-T88) → Block T51-T65 (toxic effects of substances) → Category T59 (toxic effect of other gases, fumes and vapors) → Subcategory T59.3 (lacrimogenic gas) → T59.3X2 (intentional self-harm intent) → T59.3X2S (sequela episode). Coders working on intracranial hemorrhage ICD-10 codes will recognise the same Chapter 19 hierarchy logic applied here.

Code breakdown: understanding each character of T59.3X2S

Each character in T59.3X2S carries a specific coding instruction. Misreading any one position produces an invalid code structure or, worse, an incorrect intent classification that creates a legal documentation error.

The placeholder X is not optional. T59.3 only has four characters before the decimal, meaning the code needs one extra placeholder to push the intent and episode characters into positions 6 and 7. Omitting X produces “T59.32S,” which is an invalid code structure and an automatic payer rejection. Verify against the CDC/NCHS ICD-10-CM web tool whenever code structure questions arise.

What “sequela” means for T59.3X2S coding

The 7th character S designates a sequela encounter, meaning the active toxic exposure has concluded and the patient is now being treated for a residual or late effect that persists after healing. Per ICD-10-CM Official Guidelines Section I.B.10, sequela coding requires two codes: T59.3X2S plus a separate code identifying the specific residual condition. The sequela code alone does not fully describe why the patient is presenting today.

A common error is applying S before the acute treatment phase has genuinely concluded. If the patient is still receiving treatment directly for the toxic exposure itself, A or D is correct. Switching to S prematurely violates ICD-10-CM Official Guidelines and may constitute a documentation inaccuracy. When coding situational anxiety as a secondary condition following the toxic exposure event, confirm the sequela character is appropriate before adding that code to the claim.

T59.3X2S vs. related codes: choosing the right code

The intent character and episode character together narrow T59.3X2S to a very specific clinical scenario. Confusing either produces a different code entirely, with different legal and billing implications.

Coding as accidental (T59.3X1S) when the record explicitly documents self-harm is a classification error. It understates the clinical picture, may affect mental health follow-up coordination, and can trigger an audit when the rest of the record tells a different story. When intent is genuinely unclear from the documentation, T59.3X4S (undetermined) is the correct choice. Coders working on ICD-10 coding for neurodevelopmental conditions alongside this code should verify each code’s intent and episode characters independently.

What is lacrimogenic gas? Clinical context for coders

Lacrimogenic gas is any chemical agent that causes tearing, burning, and temporary visual impairment upon mucous membrane contact. The ICD-10-CM category T59.3 groups all such agents together regardless of their specific chemical composition.

Agents classified under lacrimogenic gas for coding purposes include CS gas (2-chlorobenzalmalononitrile), CN gas (chloroacetophenone), oleoresin capsicum (OC) spray, and combination aerosols containing multiple irritants. Per published toxicology literature, these are considered “likely” to be the primary agents captured in T59.3 encounters, though the ICD-10-CM tabular does not enumerate specific chemical names.

Late effects (sequelae) that may persist after acute exposure and justify the S episode include:

• Chronic conjunctivitis or keratoconjunctivitis
• Reactive airways dysfunction syndrome (RADS) or persistent cough
• Contact dermatitis or chemical sensitisation of exposed skin
• Psychological sequelae arising from the self-harm context, coded separately (e.g. anxiety or adjustment disorder codes from the F40-F48 range)

Documentation should identify the agent by name where possible. “Tear gas exposure” is acceptable if the specific formulation is not documented, but the provider must note it was lacrimogenic in nature to support T59.3 rather than a more general toxic gas category.

Required external cause coding with T59.3X2S

T59.3X2S already encodes intent within the code structure (character 2 = intentional self-harm), so T59.3X2S is not paired with a separate X71-X83 external cause intent code the way a T-code without intent encoding might be. However, ICD-10-CM Official Guidelines recommend reporting place-of-occurrence (Y93) and activity (Y93) codes, and some payers enforce this as a hard requirement.

Sequence the codes as follows when T59.3X2S is the reason for the encounter:

1. T59.3X2S – the toxic effect code with intent and episode (principal/first-listed)
2. Residual condition code – the specific late-effect condition being treated today (e.g. J68.3 for reactive airway disease, H10.10 for chronic conjunctivitis, or appropriate F-code for psychological sequela)
3. Place-of-occurrence code (Y93) – if documented and required by payer policy
4. Activity code (Y93) – if documented and required by payer policy

Do not assert that any particular external cause code is universally required – payer policies vary. Review each payer’s LCD and billing guidelines, and consult medical billing compliance guidance when confirming payer-specific sequencing requirements. Practices using electronic claims via Claim.MD can validate code combinations in real time before submission to the payer, catching sequencing issues before they become denials.

Documentation requirements to support T59.3X2S

Four elements must appear in the clinical record to justify T59.3X2S on a claim. Missing any one shifts the code to a less specific or incorrect alternative.

1. Identification of lacrimogenic gas as the toxic agent. The note must name the agent or describe it in terms that unambiguously map to T59.3 (tear gas, CS gas, pepper spray, or similar). “Chemical exposure” without further specificity does not support T59.3 over a more general code.
2. Explicit documentation of intent = intentional self-harm. This cannot be inferred from clinical context. The provider must state the patient intentionally self-administered or self-exposed to the agent. A note that merely records “patient presented after chemical exposure” without specifying self-harm intent defaults to accidental (T59.3X1S).
3. Confirmation this is a sequela encounter. The record must show that the acute toxic episode has concluded and the patient is being seen today for a residual condition. Phrases like “late effect of prior tear gas exposure,” “residual reactive airway disease following prior chemical exposure,” or “ongoing conjunctivitis as a consequence of past lacrimogenic agent exposure” anchor the S episode character.
4. Documentation of the specific residual condition being treated. A sequela code without an identified late-effect condition is clinically incomplete and payer-non-compliant. The residual condition must be named, diagnosed, and linked back to the original toxic exposure in the record.

Practices that manage ongoing patient records for sequela follow-up benefit from structured clean claim submission workflows that ensure documentation is captured in a form that maps cleanly to ICD-10-CM requirements. Pabau’s claims management software supports pre-submission validation so incomplete code pairs are flagged before a claim leaves the practice. For broader coding context, medical billing fundamentals explains how ICD-10-CM codes feed into the full revenue cycle.

Common claim denial reasons for T59.3X2S

T59.3X2S claims deny for predictable reasons. Each maps to a specific documentation or coding gap that can be identified and fixed before submission.

Appealing a denial for any of the first three triggers requires submitting the relevant section of the clinical note with a cover letter explaining why the specific code is supported. For intent-character mismatches, include the exact language from the provider’s note. For missing residual condition codes, include an amended claim with the secondary code and a brief explanation of the late-effect condition.

Review denial codes in medical billing to understand how payer CARC codes map to each denial type, and consult denial management strategies for systematic appeal workflows. Practices that route claims through revenue cycle management processes tend to catch these errors at the pre-submission stage rather than at the remittance stage.

Reduce diagnostic code claim denials before they happen

Pabau’s claims management tools validate ICD-10-CM code pairs, flag missing secondary codes, and route clean claims through Claim.MD before they reach the payer. Book a demo to see how it works for your practice.

Book a demo

ICD-10-CM code hierarchy: where T59.3X2S sits

Understanding the full hierarchy helps when navigating payer LCD policies, crosswalk tools, or audit queries that reference parent categories rather than specific codes.

• Chapter 19 (S00-T88): Injury, poisoning, and certain other consequences of external causes
• Block T51-T65: Toxic effects of substances chiefly nonmedicinal as to source
• Category T59: Toxic effect of other gases, fumes, and vapors (siblings include T59.0 nitrogen oxides, T59.1 sulfur dioxide, T59.2 formaldehyde)
• Subcategory T59.3: Lacrimogenic gas (covers all tear-producing agents regardless of specific formulation)
• T59.3X2: Intentional self-harm (non-billable without 7th character)
• T59.3X2S: Sequela – the billable endpoint

The ICD List free lookup tool at ICD List allows coders to navigate the full T59 hierarchy visually, which is useful when verifying sibling code ranges or confirming that no more specific subcategory exists for a given agent.

Conclusion

T59.3X2S is a narrow, high-specificity code that demands four things from the clinical record: the right agent (lacrimogenic), the right intent (intentional self-harm), the right episode (sequela), and a paired code for the residual condition. Missing any one produces a denial or a classification error with potential legal implications for the patient’s record.

Pabau’s claims management software checks ICD-10-CM code pairs at the point of submission, flags incomplete sequela claim structures, and routes validated claims through the Claim.MD clearinghouse. To see how that pre-submission validation works in practice, book a demo with the Pabau team.

Continue your research

Need a framework for clean ICD-10-CM claim submission? Clean claim submission outlines the documentation and code-pair standards that prevent rejections at clearinghouse level.

Want to understand how denial codes map to specific claim errors? Denial management in healthcare covers CARC code interpretation and systematic appeal workflows.

Looking for the broader revenue cycle context for diagnostic coding? Revenue cycle management explains how ICD-10-CM codes feed into payment posting and remittance reconciliation.

Frequently Asked Questions